Artiva Biotherapeutics, Inc. · NASDAQ:ARTV

RA Capital Nexus Fund III, L.P. bought 41,319 Artiva Biotherapeutics, Inc. shares (Form 4)

Traded Jul 24, 2026 · Filed Jul 28, 2026

On Jul 24, 2026, RA Capital Nexus Fund III, L.P. (Director) bought 41,319 Artiva Biotherapeutics, Inc. shares at US$9.99 for US$413K, leaving 17,283,802 shares. Filed Jul 28, 2026 (Form 4).

Bought
41,319 shares
Price
US$9.99
Value
US$413K
Holding after
17,283,802 shares (held indirectly)
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 24, 2026Common StockBuy41,319US$9.9917,283,802Indirect

Source

View original at SEC

Related